dc.contributor.author | Nahnsen, Sven | |
dc.contributor.author | Lemke, Steffen | |
dc.date.accessioned | 2024-01-09T12:35:41Z | |
dc.date.available | 2024-01-09T12:35:41Z | |
dc.date.issued | 2023-06 | |
dc.identifier.uri | http://hdl.handle.net/10900/149106 | |
dc.language.iso | en | de_DE |
dc.publisher | Elsevier | de_DE |
dc.relation.uri | https://doi.org/10.1016/S0168-8278(23)01323-5 | de_DE |
dc.subject.ddc | 004 | de_DE |
dc.title | Chromosome engineering and CRISPR-Cas9 viability screening reveals increased metastatic capacity targetable by patient-specific synthetic lethality | de_DE |
dc.type | Article | de_DE |
utue.personen.roh | Nahnsen, Sven | |
utue.personen.roh | Roessler, Stephanie | |
utue.personen.roh | Schirmacher, Peter | |
utue.personen.roh | Marquardt, Jens U. | |
utue.personen.roh | Goeppert, Benjamin | |
utue.personen.roh | Albrecht, Thomas | |
utue.personen.roh | Pusch, Stefan | |
utue.personen.roh | Jauch, Anna | |
utue.personen.roh | Eiteneuer, Eva | |
utue.personen.roh | Sticht, Carsten | |
utue.personen.roh | Ibberson, David | |
utue.personen.roh | Castven, Darko | |
utue.personen.roh | Sugiyanto, Raisatun N. | |
utue.personen.roh | Fritzsche, Sarah | |
utue.personen.roh | Lemke, Steffen | |
utue.personen.roh | Dreher, Emely | |
utue.personen.roh | Huth, Thorben | |
dcterms.isPartOf.ZSTitelID | POSTER PRESENTATIONS: LIVER TUMOURS EXPERIMENTAL AND PATHOPHYSIOLOGY | de_DE |
Files | Size | Format | View |
---|---|---|---|
There are no files associated with this item. |